The human IgG1λ anti-CD73 monoclonal antibody oleclumab (MEDI9447) enhanced T-cell activity and demonstrated anti-tumor effects in advanced colorectal cancer, pancreatic ductal adenocarcinoma, and NSCLC in the first-in-human study [92]. Here, NT5E is linked to pancreatic ductal adenocarcinoma.